Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan

被引：0
|
作者：
Suzuki, Sho [1 ,2 ]
Ishibashi, Fumiaki [1 ,2 ]
Gotoda, Takuji [3 ]
机构：
[1] Int Univ Hlth, Dept Gastroenterol, Ichikawa, Japan
[2] Welf Ichikawa Hosp, Ichikawa, Japan
[3] Nihon Univ, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
来源：
INTERNAL MEDICINE | 2023年 / 62卷 / 16期
关键词：
Helicobacter pylori; clarithromycin resistance; penicillin allergy; vonoprazan; THERAPY;
D O I：
10.2169/internalmedicine.1282-22
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2299 / 2300
页数：2
相关论文
共 50 条
  • [31] Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori
    Mori, Naoyoshi
    Nishiura, Yuuki
    Suga, Daisuke
    Moritani, Isao
    Yamanaka, Yutaka
    Ooya, Yumi
    Inoue, Hidekazu
    Takase, Koujirou
    Hioki, Masato
    Shiraki, Katsuya
    BIOMEDICAL REPORTS, 2018, 9 (02) : 169 - 174
  • [32] Vonoprazan-based rescue eradication therapy for patients who have ever failed in the eradication of Helicobacter pylori
    Furuta, T.
    Ichikawa, H.
    Kagami, T.
    Suzuki, T.
    Yamade, M.
    Hamaya, Y.
    Iwaizumi, M.
    Osawa, S.
    Sugimoto, K.
    HELICOBACTER, 2016, 21 : 82 - 82
  • [33] Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?
    Abadi, Amin Talebi Bezmin
    Ierardi, Enzo
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [34] The safety and effectiveness of vonoprazan-based Helicobacter pylori eradication therapy; a prospective post-marketing surveillance
    Ashida, Kiyoshi
    Honda, Youichirou
    Sanada, Katsuyuki
    Takemura, Yukiko
    Sakamoto, Shigeru
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (12) : 1255 - 1261
  • [35] An Analysis of the High Eradication Rate for Vonoprazan-Based Triple Therapy Against Helicobacter pylori Resistant to Clarithromycin
    Ohta, Hidetoshi
    Sagawa, Tamotsu
    GASTROENTEROLOGY, 2016, 150 (04) : S677 - S677
  • [36] Pre-treatment with proton pump inhibitors decreases the success of primary Helicobacter pylori eradication using a vonoprazan-based regimen
    Shinozaki, Satoshi
    Osawa, Hiroyuki
    Sakamoto, Hirotsugu
    Hayashi, Yoshikazu
    Kobayashi, Yasutoshi
    Miura, Yoshimasa
    Lefor, Alan Kawarai
    Yamamoto, Hironori
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2018, 34 (08): : 456 - 460
  • [37] Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
    Sugimoto, Mitsushige
    Yamaoka, Yoshio
    FRONTIERS IN PHARMACOLOGY, 2019, 9
  • [38] Research trends on vonoprazan-based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023
    Du, Ren-Chun
    Ouyang, Yao-Bin
    Lu, Nong-Hua
    Hu, Yi
    HELICOBACTER, 2023, 28 (05)
  • [39] Long term impact of vonoprazan-based Helicobacter pylori treatment on gut microbiota and its relation to post-treatment body weight changes
    Suzuki, Sho
    Gotoda, Takuji
    Takano, Chika
    Horii, Toshiki
    Sugita, Tomomi
    Ogura, Kanako
    Ichijima, Ryoji
    Kusano, Chika
    Ikehara, Hisatomo
    HELICOBACTER, 2021, 26 (06)
  • [40] Vonoprazan-based third-line triple therapy in Helicobacter pylori eradication and study of the diversity of antimicrobial susceptibilities
    Yano, Yukari
    Mizuta, Hiroshi
    Ono, Masafumi
    Nagano, Sho
    Tsuda, Hisako
    Kitagawa, Tatsuya
    Hashiba, Motoi
    Okamoto, Nobuto
    Kira, Mizuki
    Takeuchi, Hiroaki
    Matsumura, Yoshihisa
    Saibara, Toshiji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 95 - 95
12345